| Net Cash Provided by (Used in) Operating Activities |
$466 |
USD |
|
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$10,250 |
USD |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
10,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$9,784 |
USD |
|
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$2,300 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$11,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
|
Q3 2025 |
Q3 2025 |